Recent AMLX News
- Form 8-K - Current report • Edgar (US Regulatory) • 12/30/2024 12:50:30 PM
- Amylyx Pharmaceuticals Announces Pivotal Phase 3 LUCIDITY Trial Design for GLP-1 Receptor Antagonist (Avexitide) in Post-Bariatric Hypoglycemia • Business Wire • 12/04/2024 12:30:00 PM
- Amylyx Pharmaceuticals to Present at the 7th Annual Evercore ISI HealthCONx Conference • Business Wire • 11/27/2024 02:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2024 01:22:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2024 12:07:29 PM
- Amylyx Pharmaceuticals Reports Third Quarter 2024 Financial Results • Business Wire • 11/07/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/07/2024 12:24:39 AM
- Amylyx Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024 • Business Wire • 11/04/2024 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2024 01:12:58 PM
- Amylyx Pharmaceuticals Announces Positive Topline Results from Phase 2 HELIOS Clinical Trial Demonstrating Sustained Improvements with AMX0035 in People Living with Wolfram Syndrome • Business Wire • 10/17/2024 01:00:00 PM
- Amylyx Pharmaceuticals to Host Virtual Webcast to Discuss Topline Results from Phase 2 HELIOS Study of AMX0035 in Wolfram Syndrome on October 17, 2024 • Business Wire • 10/15/2024 01:00:00 PM
- Kuehn Law Encourages Investors of Amylyx Pharmaceuticals, Inc. to Contact Law Firm • PR Newswire (US) • 10/03/2024 07:06:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2024 10:53:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2024 10:53:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2024 10:48:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/25/2024 09:56:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/16/2024 09:39:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/09/2024 08:05:06 PM
- Amylyx Pharmaceuticals to Participate in Upcoming Investor Conferences • Business Wire • 08/28/2024 12:30:00 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 08/26/2024 10:49:57 PM
- Amylyx Pharmaceuticals Announces Publication of Data Showing the Encouraging Effects of AMX0035 on Cerebrospinal Fluid Biomarkers of Core Alzheimer’s Disease Pathology and Neurodegeneration • Business Wire • 08/12/2024 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 11:14:15 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 11:09:33 AM
- Amylyx Pharmaceuticals Reports Second Quarter 2024 Financial Results • Business Wire • 08/08/2024 11:00:00 AM
- Amylyx Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 8, 2024 • Business Wire • 08/05/2024 01:00:00 PM
The Crypto Company Highlights Blockchain Training Alliance's Successes and Momentum for 2025 • CRCW • Dec 26, 2024 8:58 AM
Hertz Energy Provides Antimony and Critical Minerals Projects Update and Announces Financing • HZLIF • Dec 20, 2024 9:00 AM
North Bay Resources Announces Arrival of 42 Tons Gold Ore at Bishop Gold Mill, California • NBRI • Dec 20, 2024 9:00 AM
Consumer Automotive Finance Subsidiary Drago Knives Narrows Down Potential Partner to Manufacture Patented Throwing Knives • CAFI • Dec 20, 2024 9:00 AM
$ASNS - Is this the Next Big Cybersecurity Stock? How Actelis Networks is Revolutionizing Critical Infrastructure Protection • ASNS • Dec 20, 2024 8:50 AM
UAV Corp's (UMAV), Skyborne Technology to Build "SKY" Hangar at Its Costin Airport Scheduled for Groundbreaking Ceremony Winter 2025 • UMAV • Dec 20, 2024 8:30 AM